Royalty Pharma PLC (RPRX)

Add to Watchlists
Create an Alert
Quickflows
37.50 0.00  0.00% NASDAQ Oct 22, 16:00 37.52 +0.02  +0.05% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All RPRX News

News

View All Events

Events

Date Type Description
11/18/2021 Dividends 0.17 Normal dividend, declared October 15, 2021 and paid December 15, 2021
11/10/2021 Earnings Results Q3 2021 Earnings Results
11/10/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
08/19/2021 Dividends 0.17 Normal dividend, declared July 16, 2021 and paid September 15, 2021
08/11/2021 Earnings Results Q2 2021 Earnings Results
08/11/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/24/2021 09:00 EST AGM 2020 Annual General Meeting
05/19/2021 Dividends 0.17 Normal dividend, declared April 15, 2021 and paid June 15, 2021
05/11/2021 Earnings Results Q1 2021 Earnings Results
05/11/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 2.239B
Total Expenses (TTM) 439.66M
Net Income (TTM) 971.62M

Balance Sheet View Statement

Total Assets (Quarterly) 16.51B
Total Liabilities (Quarterly) 6.110B
Shareholders Equity (Quarterly) 5.734B

Cash Flow Statement View Statement

Cash from Operations (TTM) 2.132B
Cash from Investing (TTM) -2.226B
Cash from Financing (TTM) -1.086B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings.
  • URL: https://www.royaltypharma.com
  • Investor Relations URL: https://www.royaltypharma.com/investors/
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Value
  • Next Earnings Release: Nov. 10, 2021
  • Last Earnings Release: Aug. 11, 2021
  • Next Ex-Dividend Date: Nov. 18, 2021
  • Last Ex-Dividend Date: Aug. 19, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 37.50
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
IHE iShares US Pharmaceuticals ETF 4.52%
XPH SPDR® S&P Pharmaceuticals ETF 4.33%
MSKLX Morgan Stanley Inst Discovery L 2.91%
FORH Formidable ETF 2.78%
PILL Direxion Daily Phrmctcl&MdclBl3XShrsETF 2.78%
CPOCX Morgan Stanley Insight L 2.77%
TCPWX Transamerica Capital Growth R6 2.49%
MSHLX Morgan Stanley Inst Growth L 2.03%
IBBQ Invesco Nasdaq Biotechnology ETF 1.40%
FACTX Fidelity Advisor® Health Care M 1.20%
FSPHX Fidelity® Select Health Care 1.17%
BIB ProShares Ultra Nasdaq Biotechnology 1.16%

Comparables

Edit
AGIO Agios Pharmaceuticals Inc
SAGE Sage Therapeutics Inc
DVA DaVita Inc
BCRX BioCryst Pharmaceuticals Inc
INCY Incyte Corp

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.